Iterum Therapeutics plc Ordinary Share is a pharmaceutical company focused on the development and commercialization of innovative anti-infectives. With a commitment to address the growing global threat of drug-resistant pathogens, Iterum aims to provide effective and safe treatments for patients in need. Its robust pipeline and strategic partnerships position it at the forefront of the fight against antimicrobial resistance.
